Zipline is a drug tracked in our intelligence system with 5 linked articles.
DOT delays BVLOS drone-rule while prioritizing thorough discussion to avoid future tech lock-in; investors crave regulatory certainty amid a 240-day deadline timeline.
Ferrari’s Luce EV defied early haters by hitting sales targets quickly and hints at strong demand in China, while adjacent TechCrunch pieces spotlight regulatory and funding shifts shaping autonomous tech, drones, fusion, and critical minerals.
Redwood Materials hires former Tesla CFO Deepak Ahuja and says an IPO is “too early,” after raising >$2B in total with a $6B+ valuation on a $425M Series E, while restructuring and expanding its energy-storage business.
Freestyle provides sub-second Linux VM sandboxes for AI coding agents with live forking, persistent state, GitHub sync, and granular controls, targeting scalable agent workloads.
Zipline secures $200M in new funding, following a January round valuing the company at $7.6B.
Zipline secures $600M in new funding and plans to expand drone delivery to at least four additional U.S. states in 2026.
Subscribe for real-time drug updates and unlimited access to our intelligence platform.